The global disposable endoscopes market is expected to expand at a CAGR of 15.04% through 2035, driven by rising infection prevention initiatives, adoption of single-use endoscopes, and minimally invasive procedures. North America leads with 38.45% market share, while Asia Pacific records the fastest growth. Hospitals dominate the end-user segment with 55.36% market share, with ambulatory surgical centers showing the highest growth potential.

The AI in orthopedic surgery market is experiencing remarkable growth with a projected CAGR of 27.2% through 2030. Key drivers include rising musculoskeletal disorders, AI-assisted surgical planning, robotic surgical systems integration, and enhanced implant placement precision. North America leads the market, while Asia-Pacific and Europe show growing segments despite tariff-related challenges.

A comprehensive patent landscape analysis of surgical navigation systems reveals 2,524 patents filed globally from 2010-2025, with the United States leading at 1,204 patents. The global market was valued at USD 8.38 billion in 2024 and is projected to reach USD 18.47 billion by 2030 at a 14% CAGR. Key drivers include AI-guided support, augmented reality, and robotic integration, with North America dominating and Asia-Pacific as the fastest-growing region. Major players include Brainlab AG, Medtronic, and Stryker.

A comprehensive RF-detection patent landscape report covering 1,248 patents filed from 2010-2024 shows the US leading with 490 patents followed closely by China with 479 patents. The global RF-detection market was valued at USD 3.5 billion in 2023 and is projected to reach USD 4.6 billion by 2032 with a 6.5% CAGR. Key application areas include military, healthcare, public safety, and transportation, with North America dominating regional sales at USD 1.6 billion in 2023.

The global microcatheter market is valued at USD 1.05 billion in 2025 and is projected to reach USD 1.79 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by increasing adoption of minimally invasive cardiovascular and neurovascular procedures, rising prevalence of cardiovascular and neurovascular disorders, and advancements in catheter technologies. Aspiration microcatheters lead with 36% market share, while steerable microcatheters are the fastest-growing segment. North America dominates with 34% of global revenues, with Asia-Pacific emerging as the fastest-growing region.

SpyGlass Pharma, a late-stage biopharmaceutical company, announced the appointment of Shannon Treviño as general counsel. Treviño brings extensive legal experience from her previous role as General Counsel at Inari Medical, where she oversaw the company's $4.9 billion acquisition by Stryker. She will support SpyGlass's Phase 3 trials for its BIM-IOL System, a drug delivery device designed to treat glaucoma and ocular hypertension.

ThruFlo Endovascular announced completion of seed funding led by Atlas MedInnovation to develop a novel bifurcated flow diverter for treating cerebral aneurysms at vessel branch points. The device addresses a significant gap in the market where approximately 60% of intracranial aneurysms occur. Proceeds will fund R&D operations, device design completion, pre-clinical studies, and FDA IDE application submission.

Dr. Kornelis Poelstra, a Las Vegas-based spine surgeon, has completed his 2,000th robotic-assisted spine procedure after 16 years of experience across multiple robotic platforms including SpineAssist, Renaissance, Mazor X, LEM, and Mako. The milestone reflects growing clinical experience in robotic-guided spine surgery, with published studies suggesting these systems may improve implant placement accuracy compared to conventional techniques.

The global computer vision in healthcare market is projected to grow from $4.37 billion in 2026 to $33.4 billion by 2036, at a CAGR of 22.6%. Growth is driven by AI-integrated diagnostic systems, radiologist shortages, and precision medicine adoption. Software and medical imaging segments lead the market, while Asia-Pacific is expected to see the fastest regional growth.

Stryker has completed its acquisition of Amplitude Vascular Systems, a Boston-based medical device company specializing in intravascular lithotripsy (IVL) technology for treating complex peripheral arterial disease. The acquisition strengthens Stryker's peripheral vascular portfolio by integrating AVS's innovative CO₂-generated pressure wave technology with Stryker's resources and scale.

Stryker Corporation announced a quarterly dividend increase of 4.8% to $0.88 per share, payable July 31, 2026. The company reported first quarter 2026 operating results with net sales increasing 2.6% to $6.0 billion, demonstrating continued growth in its medical technology business across MedSurg, Neurotechnology, and Orthopaedics segments.

Becton Dickinson (BDX) trades at a 13x forward P/E multiple, representing a significant discount to medtech peers despite strong fundamentals including 60% U.S. infusion pump market share, 90%+ recurring revenue, and record 25% adjusted operating margins. The post-spin-off transition year narrative masks an emerging pure-play MedTech company with billion-dollar growth platforms in GLP-1 drug delivery and connected care, supported by $4 billion in fresh capital deployment and ongoing margin expansion targeting 26%+ territory.